Market Access Views & Analysis

Views & Analysis

Market Access

Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery among those outside the sector.

Market Access

What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?

Views & Analysis

Part of the drive for strengthening EU cooperation on health technology assessment (HTA) is to tackle duplication of work

Views & Analysis

Patient centricity is no longer a buzzword, it’s an essential way of conducting business that makes both ethical and commercial sense.

Views & Analysis

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

Views & Analysis

Now is the time to work more harmoniously together to improve patient access to innovative treatments.